Sigma Healthcare Ltd
ASX:SIG
Sigma Healthcare Ltd
ASX:SIG
Price:
1.235 AUD
-1.98%
Market Closed
Updated:
May 18, 2024
P/E
Price to Earnings
Price to Earnings
430.2
Current
12.9
Median
24.1
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=430.2
Market Cap
/
1.9B
Net Income
4.5m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
1.9B AUD | 430.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
73.4B USD | 24.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
44.3B USD | 23.9 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 43.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.6B USD | 24.7 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
68.5B HKD | 7 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.8B EUR | 50 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.2B CNY | 19.7 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52.6B CNY | 13.9 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
hidden
2-Years Forward
P/E
hidden
3-Years Forward
P/E
hidden
You don't have any saved screeners yet
